Between discourse and being the commodification of pharmaceuticals in late capitalism

Communication Review

Volumn 7, Issue 1, 2004, Pages 15-34

  Tracy, James F ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57649219024     PISSN: 10714421     EISSN: 15477487     Source Type: Journal    
DOI: 10.1080/10714420490280170     Document Type: Article

References (58)

1. Adams, C., 2002. FDA cuts back on warnings as critics see enforcement easing. Wall Street Journal,: A3 1 October
2. Beatty, S., 2002. PBS and corporate underwriters: Too close for comfort?. Wall Street Journal,: B1 11 July
3. Begley, S., 2002. What goes into and brand name? A letter at a time. Wall Street Journal,: D1 31 August
4. Bravin, J., Naik, G., and Adams, C., 2002. US supports Glaxo, asks judge to rethink blocking of Paxil ads. Wall Street Journal,: B2 21 August
5. Bowe, C., 2003. Wyeth earnings easily surpass Wall Street expectations. Financial Times,: 25 24 April
6. Burton, T. M., 2002. Reigning in drug advertising. Wall Street Journal,: B1 13 March
7. Carey, A., 1997. Taking the risk out of democracy: Corporate propaganda versus freedom and liberty, Edited by: Lohrey, A., Urbana, IL: University of Illinois Press.
8. Carey, J., and Barrett, A., 2001. Drug prices: What’s fair?. Business Week,: 61–70. 10 Decemberhttp://www.csa.com/htbin/linkabst.cgi?issn=0007-7135&vol=&iss=&firstpage=61
9. Chaker, A. M., 2003. Do you need a pill to stop shopping?. Wall Street Journal,: D1 2 January
10. DeGrandpre, R., 1999. Ritalin nation: Rapid fire culture and the transformation of human consciousness, New York:: W.W. Norton.
11. Ewen, S., 1988. All consuming images: The politics of style in contemporary culture, New York:: Basic Books.
12. Frank, T., 2000. One market under god: Extreme capitalism, market populism, and the end of economic democracy, New York:: Anchor Books.
13. Fuhrmans, V., and Naik, G., 2002. In Europe: Prescription-drug ads are banned—and health costs lower. Wall Street Journal,: B1 15 March
14. Glader, P., 2002. From the maker of Effexor: Campus forums on depression. Wall Street Journal,: B1 10 October
15. Habermas, J., 1970. Toward a rational society: Student protest, science, and politics, Boston: Beacon Press.
16. Harris, G., 2002. Drug makers offer coupons for free prescriptions. Wall Street Journal,: B1 13 March
17. Harris, G., 2003. Drug firms’ “bad” year wasn’t so bad. Wall Street Journal,: B4 21 February
18. Harris, G., and Slater, J., 2003. Drug makers see “branded generics” eating into profits. Wall Street Journal,: A1 17 April
19. Healy, D., 1999. The antidepressant era, Cambridge, MA: Harvard University Press.
20. Healy, D., 2002. The creation of psychopharmacology, Cambridge, MA:: Harvard University Press.
21. Hensley, S., 2002. Doctors are found to be susceptible to drug pitches. Wall Street Journal,: D6 12 December
22. Hensley, S., 2003. Concern is growing over spike in prices of prescription drugs. Wall Street Journal,: D4 15 April
23. Horkheimer, M., 1999. Critical theory: Selected essays, New York: Continuum.
24. Jhally, Sut., 1990. The codes of advertising: Fetishism and the political economy of meaning in the consumer society, NewYork: Routledge.
25. Klein, N., 1999. No logo: Taking aim at the brand bullies, New York: Picador.
26. Kreling, D. H., Mott, D. A., and Wiederholt, J. B., 2001. Prescription drug trends: A chartbook update, Kaiser Family Foundation.
27. Landers, P., 2002a. Western drug firms profit as Japan opens its market. Wall Street Journal.,: A1 2 December
28. Landers, P., 2002b. Waiting for Prozac: Drug firms push Japan to change view of depression. Wall Street Journal,: A1 9 October
29. Levine, B. E., 2002. Commonsense rebellion: Debunking psychiatry, confronting society, New York: Continuum.
30. Liebenau, J., 1987. Medical science and medical industry: The formation of the American pharmaceutical industry, Baltimore:: Johns Hopkins University Press.
31. Lippmann, W., (1997)[1922]. Public opinion, New York: Free Press Paperbacks.
32. Marchand, R., 1985. Advertising and the American dream: Making way for modernity, 1920–1940, Berkeley:: University of California Press.
33. Marcuse, Herbert. 1964. One dimensional man, Boston: Beacon.
34. Marx, Karl. 1906. Capital: A critique of political economy, Edited by: Aveling, Edward. New York: Random House.
35. Mattelart, A., 1990. Advertising international: The privatisation of public space, Edited by: Chanan, Michael. London: Routledge.
36. McGinley, L., and Hensley, S., 2002. Drug makers aim to protect patents. Wall Street Journal,: A3 3 May
37. McGough, R., 2003. Screening program aims to prevent suicide by teens. Wall Street Journal.,: B5 21 February
38. Mosco, V., 1996. The political economy of communication: Rethinking and renewal, Thousand Oaks, CA: Sage. http://www.thenation.com/doc.mhtml?i = 2002085&s = newman20020725
39. Newman, N., 2002. “ Big pharma, bad science ”. In The Nation 25 July
40. Newswise. 2002. Venlafaxine XR, first SNRI studied for social anxiety disorder 28 June. Retrieved 24 April, 2003, fromhttp://www.newswise.com/articles/2002/6/SAD.PNY.html
41. O’Connell, V., 2002. Agencies join in drug development. Wall Street Journal,: B1 13 March
42. Oransky, I., and Lenzer, J., 2002. Ties to drug manufacturers deform medical reviews. USA Today,: A11 1 August
43. 2003a. Zoloft receives FDA approval for treatment of social anxiety disorder. PR Newswire, 10 February
44. 2003b. Effexor XR approved for the treatment of social anxiety disorder. PR Newswire, 11 February
45. Peterson, M., 2003. A respected face, but is it news or an ad? New York Times nytimes.com. 7 May Retrieved 12 May, 2003 athttp://www.nytimes.com/2003/05/07/business/media/07DRUG.html
46. Rampton, S., and Stauber, J., 2001. Trust us, we’re experts! How the industry manipulates science and gambles with your future, New York:: Jeremy P. Tarcher/Putnam.
47. Siegel, M., 2002. “ Fighting the drug (ad) wars ”. In The Nation, 30 May Retrieved 27 April, 2003 athttp://www.thenation.com/doc.mhtml?i = 20020617&s = siegel&c = 1
48. Shook, David., 2003. “ Forest Labs: Feeling no pain. 25 March ”. In Business Week Online http://www.businessweek.com/bw50/content/mar2003/a3826021.htm
49. Silverstein, K., 1999. “ Millions for Viagra, pennies for diseases of the poor: Research money goes to profitable lifestyle drugs ”. In The Nation. 19 July Retrieved on 27 April, 2003 athttp://www.thenation.com/doc.mhtml?i = 19990719&s = silverstein
50. Starr, P., 1982. The social transformation of American medicine: The rise of a sovereign profession and the making of a vast industry, New York:: Basic Books.
51. Stole, I., 2001. “ Advertising ”. In Culture works: The political economy of culture, Edited by: Maxwell, R., 83–106. Minneapolis:: University of Minnesota Press.
52. Swann, J. P., 1988. Academic scientists and the pharmaceutical industry: Cooperative research in twentieth century America, Baltimore: Johns Hopkins University Press.
53. Vranica, S., 2002. Patient channel to blast ads at bedridden. Wall Street Journal,: B1
54. 2003. Human genetic map is done. Wall Street Journal, 15 April: D5
55. Walters, J., 2002. “ Prozac research targets local girls; PMS survey recruiting tool ”. In Hamilton Spectator, 2 November A1
56. Whitaker, R., 2002. Mad in America: Bad science, bad medicine, and the enduring mistreatement of the mentally ill, Cambridge, MA: Perseus.
57. Young, J. R., 2003. “ Prozac campus: More students seek counseling and take psychiatric medication ”. In Chronicle of Higher Education A37
58. Zimmerman, A., and Armstrong, D., 2002. How drug makers use pharmacies to push pricey pills. Wall Street Journal,: A1